Organoids are three-dimensional miniature models of organs, grown in a dish. They have become a valuable tool for studying ...
Researchers at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy found that ...
Researchers have found a reliable way to grow helper T cells from stem cells, solving a major challenge in immune-based ...
Why do some tumors spread while others remain localized? The mechanisms governing the metastatic potential of tumor cells ...
A hidden communication network between brain cells and glioblastoma tumors may be key to slowing this aggressive cancer.
Cancer Research Institute, New York, NY, USA. The cancer cell therapy landscape continues to evolve rapidly. In 2024, the first approvals of tumour-infiltrating lymphocyte (TIL) and T cell receptor ...
Scientists at the Icahn School of Medicine at Mount Sinai have developed an experimental immunotherapy that takes an ...
The preventive immunization Nous-209 works in an initial trial with patients who have 17 times the risk of developing tumors ...
ETX-19477 is a potent, selective inhibitor of poly (ADP-ribose) glycohydrolase (PARG), an enzyme that plays a role in the DNA damage response. 3,4 Upon PARG inhibition, the agent is intended to ...
Patients with severe melanoma who received the treatment were 49% less likely to die or have their cancer return, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results